Login to Your Account

OncoGenex Trades Discount for Prestige in $50M Offering

By Trista Morrison
Staff Writer

Monday, March 19, 2012

Shares of OncoGenex Pharmaceuticals Inc. fell 20.8 percent Friday after the Bothell, Wash.-based biotech priced its $50 million public offering at $12 per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription